Cargando…
Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma
Statins comprise a class of prescription drugs used for reducing cholesterol. Evidence has also showed that statins could reduce cancer incidence. However, the anti-tumor mechanism of statins has not been fully defined. Here, we found that atorvastatin inhibited proliferation of esophageal squamous...
Autores principales: | Yuan, Qiang, Dong, Christopher D., Ge, Yang, Chen, Xinhuan, Li, Zhenzhen, Li, Xin, Lu, Qiqi, Peng, Feng, Wu, Xiangyu, Zhao, Jimin, Liu, Kangdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874460/ https://www.ncbi.nlm.nih.gov/pubmed/31697643 http://dx.doi.org/10.18632/aging.102402 |
Ejemplares similares
-
Proteomics Reveal the Inhibitory Mechanism of Levodopa Against Esophageal Squamous Cell Carcinoma
por: Li, Zhenzhen, et al.
Publicado: (2020) -
TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2019) -
Correction to: TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2020) -
Tegaserod Maleate Inhibits Esophageal Squamous Cell Carcinoma Proliferation by Suppressing the Peroxisome Pathway
por: Wu, Xiangyu, et al.
Publicado: (2021) -
Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma
por: Li, Yi, et al.
Publicado: (2021)